A Multi-Center, Open Label Gene Therapy Study of RP-A501 in Male Patients With Danon Disease

A Multi-Center, Open Label Gene Therapy Study of RP-A501 in Male Patients With Danon Disease

Conditions: Danon Disease
Interventions: Genetic: RP-A501
Sponsors: Rocket Pharmaceuticals Inc.
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 21, 2023Comments OffCardiology | Cardiology Clinical Trials | Cardiology Studies | ClinicalTrials.gov | Drug Trials Near Me | US National Library of Medicine
Comments